Health Condition 1: - Health Condition 2: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: ORAL MINOXIDIL 2.5MG: Minoxidil Dose - 2.5mg Frequency - Once Daily at bed time Route - Oral Follow up - 4 weeks,8 weeks,12 weeks,16 weeks, 20 weeks and 24 weeks Duration of study - 24
Sponsors
Eras Lucknow Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: All consenting male patients in the age group of 18 55 years with AGA stage II VI Norwood-Hamilton classification visiting the dermatology OPD.
Exclusion criteria
Exclusion criteria: 1. Patients who have taken any form of treatment for AGA in the past six months. 2. Patients with hypersensitivity to minoxidil. 3. Patients with non patterned alopecia and cicatricial alopecia. 4. Patients with a history of severe systemic disease (renal, cardiovascular and hepatic). 5. Patients with a history of hypotension/hypertension, or ones on antihypertensive therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To trichoscopically assess and compare the effectiveness of oral minoxidil (2.5 mg) tablet and topical minoxidil (5%) lotion in the treatment of AGA.Timepoint: 4, 8, 12, 16, 20 and 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To see the trichoscopic response with oral minoxidil (2.5 mg) tablet in male patients with AGA. To see the trichoscopic response with topical minoxidil (5%) lotion in male patients with AGA. To assess the side effects of oral minoxidil (2.5mg) tablet and topical minoxidil (5%) lotion in male patients with AGA. Timepoint: 4, 8, 12, 16, 20 and 24 weeks | — |
Countries
India
Contacts
Public ContactDr Muskaan Manzoor
Department of Dermatology Venereology and Leprosy Eras Lucknow Medical College and Hospital
Outcome results
None listed